PUNE, India, November 7, 2017 /PRNewswire/ --
According to a new market research report "Mass Spectrometry Market by Platform (Hybrid mass spectrometry (Triple Quadrupole, QTOF & FTMS), Single mass spectrometry (Quadrupole, TOF & Ion Trap)), Application (Pharmaceuticals, Biotechnology, Environmental testing) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 5.27 Billion by 2022 from an estimated USD 3.68 Billion in 2017, at a CAGR of 7.4%.
Browse 109 Market Data Tables and 36 Figures spread through 176 Pages and in-depth TOC on "Mass Spectrometry Market"
Early buyers will receive 10% customization on this report.
The key factors which include the growth of the pharmaceutical and biotechnology industry and technological advancements in mass spectrometry are driving the growth of the global Mass Spectrometry Market during the forecast period. The growing use of mass spectrometry in emerging markets and the rising potential for the application of high-resolution mass spectrometry in healthcare are the key areas of opportunity in this market.
By technology, the hybrid mass spectrometry segment accounted for the largest share of the market in 2017
On the basis of technology, the Mass Spectrometry Market is broadly segmented into single mass spectrometry, hybrid mass spectrometry, and other mass spectrometry technologies (magnetic sector, inductively coupled plasma mass spectrometry). In 2017, the hybrid mass spectrometry segment is expected to account for the largest share of this market. The extensive applications of hybrid mass spectrometers coupled with the technological advancements in mass spectrometry are driving the growth of this segment.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=437
By application, the pharmaceutical application industry held the largest market share in 2017
Based on application, the Mass Spectrometry Market is further segmented into pharmaceutical application, biotech application, environmental testing, food and beverage testing, petrochemical applications, and other applications. In 2017, the pharmaceutical applications segment is expected to account for the largest share. Extensive use of mass spectrometry technologies at various stages of drug development processes and increase in R&D investments by pharmaceutical industries are driving the growth of the market.
North America dominated the market in 2017
North America accounted for the largest share of the Mass Spectrometry Market in 2016, followed by Europe. High usage of mass spectrometry in the pharmaceutical sector, growing funding to favor Mass Spectrometry Market in the US, high petrol and natural gas production, growing biopharmaceuticals and biotechnology research & development and fundings for innovation based projects in Canada is expected to drive market during the forecast period.
Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=437
Factors such as availability of funds for research, growing cosmetics industry in Germany, growing food safety concerns and increased investments for pharmaceuticals in the UK, favorable scenario of biotechnology and pharmaceutical industry in Italy, company's expansion in France and strong food and beverage industry in Spain are driving factors of
the European Mass Spectrometry Market.
Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), and SCIEX (Subsidiary of Danaher) (US) are the key players in the Mass Spectrometry Market. Other players involved in this market are Bruker (US), PerkinElmer (US), JEOL (Japan), Analytik Jena (Germany), Hiden Analytical (UK), Rigaku (Japan), LECO (US), and DANI Instruments (Italy).
Browse Related Reports:
Chromatography Instruments Market by Type (Systems, Detectors), Consumables (Columns) and Accessories (Auto-sampler Accessories), Applications (Life science Research, Environmental Testing, Food & Beverage Testing), and Region - Global Forecast to 2022
Glycobiology/Glycomics Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
630 Dundee Road
Northbrook, IL 60062
Email: [email protected]
Visit MarketsandMarkets™ [email protected] http://mnmblog.org/market-research/healthcare/analytical-scientific-instrumentation
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets